Biotalys NV Cash Flow Conversion Efficiency
Biotalys NV cash flow conversion efficiency. Based on the latest financial reports, Biotalys NV (BTLS) has a cash flow conversion efficiency ratio of -0.154x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.05 Million ≈ $-3.56 Million USD) by net assets (€19.81 Million ≈ $23.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Biotalys NV (2019–2024)
Cash flow conversion efficiency of Biotalys NV from 2019 to 2024. This chart illustrates how Biotalys NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Biotalys NV share price for real-time trading data and today's change.
Biotalys NV Cash Flow Conversion Ratio Explained
Biotalys NV cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Biotalys NV Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biotalys NV ranked by their cash flow conversion efficiency. Also see Biotalys NV market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TDM Berhad
KLSE:2054
|
0.043x |
|
Heidmar Maritime Holdings Corp. Common Stock
NASDAQ:HMR
|
0.991x |
|
Peace Acquisition Corp Ordinary Shares
NASDAQ:PECE
|
-0.003x |
|
Dwarikesh Sugar Industries Limited
NSE:DWARKESH
|
0.674x |
|
NH All One REIT Co Ltd
KO:400760
|
N/A |
|
Unique Engineering and Construction Public Company Limited
BK:UNIQ
|
-0.190x |
|
Viet Nam Power Development JSC
VN:VPD
|
N/A |
|
Rallybio Corp
NASDAQ:RLYB
|
0.482x |
Annual Cash Flow Conversion Efficiency for Biotalys NV (2019–2024)
The table below shows the annual cash flow conversion efficiency of Biotalys NV from 2019 to 2024. Review BTLS FCF to total liabilities ratio to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €27.61 Million ≈ $32.27 Million |
€-12.65 Million ≈ $-14.79 Million |
-0.458x | +35.91% |
| 2023-12-31 | €25.57 Million ≈ $29.89 Million |
€-18.28 Million ≈ $-21.37 Million |
-0.715x | -35.65% |
| 2022-12-31 | €38.11 Million ≈ $44.56 Million |
€-20.09 Million ≈ $-23.49 Million |
-0.527x | -85.36% |
| 2021-12-31 | €58.91 Million ≈ $68.88 Million |
€-16.75 Million ≈ $-19.59 Million |
-0.284x | +23.49% |
| 2020-12-31 | €25.65 Million ≈ $29.99 Million |
€-9.53 Million ≈ $-11.15 Million |
-0.372x | +4.76% |
| 2019-12-31 | €21.07 Million ≈ $24.64 Million |
€-8.22 Million ≈ $-9.61 Million |
-0.390x | -- |
About Biotalys NV
Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6… Read more